Chief Executive Officer

Dr Courtieu joined IntegraGen as CEO in September 2007. Prior to this, he achieved significant success within Gemini Consulting's Life Sciences division, France, as Practice Leader, and later as Vice President. Dr Courtieu's tenure with Eurostart, Bossard Gemini Consulting and Cap Gemini Ernst & Young yielded hands-on experience in improving the operational performance of pharmaceutical companies in the fields of research and development, industrial operations, supply chain & marketing and information systems.

Subsequently, Dr Courtieu held the position of Country Manager, France, at Ariba, the world leader in Spend management, assisting companies in analyzing and managing their corporate spending to achieve increased business process efficiency.

Dr Courtieu holds a MBA from the Instituto de las Estudios Superiores de la Empresa (IESE) in Barcelona, Spain. He received his doctorate in Veterinary Medicine from the Ecole Vétérinaire d'Alfort and University Paris XII, France.

Seminar 2009

Dr Bernard Courtieu spoke at the 3rd Meeting of the Pharmaceutical Industry in Barcelona. Date : November 5th, 2009.

His presentation focused on new approaches and business models to innovation for biotech markets.

More information : IESE Barcelona

Latest News

7-10 September 2009 : Prof. Andreas Ziegler, University of Lübeck, made a presentation on methods for Evaluating clinical validity in single affected offspring trio families. at 54. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie e.V. (GMDS) conference in Essen (Germany)

>> link to abstract

>> link to GMDS conference

 

9 june 2009 : Bernard Courtieu, CEO of IntegraGen, attended the AMIPS* conference on "Drug development for personalised medicine". His presentation focused on biomarkers development for Neurology.

*AMIPS : Association des Médecins des Industries des Produits de Santé (French association of Medical doctors of health industry products)

link to AMIPS